Tamiflu

Tamiflu Clear financial links have emerged between scientists behind the flu policies of the World Health Organisation and the manufacturers of Tamiflu. Was the pandemic advice given by the WHO compromised?
In 2004 the WHO issued advice that countries stockpile antivirals. By 2005 Tamiflu sales had reached $1.3 billion worldwide. Scientists behind the WHO guidelines were receiving funds from Roche, producers of the drug. Is this a dangerous threat to scientific validity? The WHO claim that conflicts of interest are "inherent in any relationship". Yet the Council of Europe argues that the critical problem is that the WHO has no obligation to make such information open to the public. "And that leaves the WHO, the scientists and the pharmaceutical companies open to every conspiracy theory under the sun". Produced in association with the British Medical Journal.
FULL SYNOPSIS

This site uses cookies. By continuing to use this site you are agreeing to our use of cookies. For more info see our Cookies Policy